tiprankstipranks
Cue Biopharma Inc (CUE)
NASDAQ:CUE
US Market

Cue Biopharma (CUE) Financial Statements

512 Followers

Cue Biopharma Financial Overview

Cue Biopharma's market cap is currently ―. The company's EPS TTM is $-1.066; its P/E ratio is -0.96; Cue Biopharma is scheduled to report earnings on September 2, 2024, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 1.72M$ 2.10M$ 1.38M$ 187.00K$ 151.23K
Gross Profit$ 1.72M$ 2.10M$ 1.38M$ 187.00K$ 151.23K
EBIT$ -12.11M$ -10.72M$ -12.95M$ -13.44M$ -14.87M
EBITDA$ -12.00M$ -10.59M$ -12.88M$ -13.40M$ -13.99M
Net Income Common Stockholders$ -12.35M$ -11.01M$ -13.19M$ -13.11M$ -14.59M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 41.03M$ 54.69M$ 57.89M$ 66.20M$ 76.29M
Total Assets$ 53.95M$ 68.89M$ 73.16M$ 81.68M$ 91.28M
Total Debt$ 13.00M$ 16.38M$ 18.04M$ 18.70M$ 19.32M
Net Debt$ -28.03M$ -38.31M$ -39.84M$ -47.49M$ -56.97M
Total Liabilities$ 23.91M$ 26.22M$ 27.16M$ 26.66M$ 25.60M
Stockholders Equity$ 30.04M$ 42.67M$ 46.00M$ 55.02M$ 65.68M
Cash Flow-
Free Cash Flow$ -9.84M$ -7.80M$ -10.37M$ -10.83M$ -10.51M
Operating Cash Flow$ -9.78M$ -7.80M$ -10.37M$ -10.83M$ -10.51M
Investing Cash Flow$ -55.00K$ 5.00M$ 5.00M$ 15.00M$ 5.00M
Financing Cash Flow$ 2.35M$ 4.59M$ 2.10M$ 388.00K$ 27.40M
Currency in USD

Cue Biopharma Earnings and Revenue History

Cue Biopharma Debt to Assets

Cue Biopharma Cash Flow

Cue Biopharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis